Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04660513
Other study ID # SGH-ENDO-GlycineTA-001
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 8, 2018
Est. completion date November 4, 2020

Study information

Verified date December 2020
Source Singapore General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Obesity, in addition to causing abnormal glucose and lipid metabolism, is also associated with altered plasma concentrations of multiple amino acids, including increased levels of branched-chain amino acids and decreased levels of glycine. The mechanisms and consequences of obesity- related glycine deficiency are unknown. The overall aim of this project is to comprehensively study glycine metabolic pathways in morbid obesity using stable-isotope tracer techniques in human subjects and validating kinetic findings using a cell model of oxidative stress. This will be a single-centre, observational study. 21 individuals with morbid obesity scheduled for bariatric surgery and 21 non-obese controls will be recruit. They will undergo different study visits and procedures and the human biological materials collected will be analysed for as per aims of the studies. We believe that the glycine metabolic pathways, possibly through the optimization of gluthathione (GSH) synthesis, may provide targets to develop novel therapeutic agents.


Description:

Metabolic tracers: 1,2-[13C2]-Glycine, 1,2-[13C2]-Glycine, 2,3,3,-[2H3]-Serine and [2H5]-Phenylalanine will be infused for quantification of various pathways associated with glycine metabolism.


Recruitment information / eligibility

Status Completed
Enrollment 42
Est. completion date November 4, 2020
Est. primary completion date November 4, 2020
Accepts healthy volunteers
Gender All
Age group 21 Years to 65 Years
Eligibility Inclusion Criteria: 1. Age: 21-65 years 2. BMI < 25 kg/m2 for non-obese controls or BMI = 32.5 kg/m2 for obese subjects scheduled for bariatric surgery 3. Able to provide informed consent Exclusion Criteria: All subjects: 1. Weight > 150 kg 2. Renal impairment (estimated creatinine clearance estimated by Cockcroft-Gault Equation < 60 ml/min) 3. Haemoglobin concentration < 10 g/L 4. Serum alanine aminotransferase or aspartate aminotransferase above 2x upper limit of normal 5. Uncontrolled hypertension (BP > 180/110 mmHg) 6. Pregnancy 7. Nursing mothers 8. Significant cardiovascular disease (e.g. acute myocardial infarction, congestive cardiac failure, ischemic heart disease, atrial fibrillation, sick sinus syndrome, supraventricular tachycardia) 9. Previous stroke 10. Uncontrolled thyroid disease 11. Surgery requiring general anaesthesia within 4-weeks before enrolment 12. Psychiatric disorders requiring medication 13. Significant alcohol intake (> 1 unit per day for women and > 2 units per day for men) 14. Subcutaneous insulin injections 15. Systemic steroid usage (eg. prednisolone, hydrocortisone, cortisone, dexamethasone) 16. Cancer within the last 5-years (except squamous cell and basal cell cancer of the skin) 17. Any factors likely to limit adherence to study protocol (e.g. dementia; alcohol or substance abuse; history of unreliability in medication taking or appointment keeping; significant concerns about participation in the study from spouse, significant other or family members) Non-obese controls 1. Known Diabetes Mellitus (diagnosed according to 2014 Ministry of Health Clinical Practice Guidelines for Diabetes Mellitus) Obese subjects 1. HbA1C < 9%

Study Design


Intervention

Procedure:
Bariatric surgery
Subjects with morbid obesity underwent bariatric surgery

Locations

Country Name City State
Singapore Singapore General Hospital Singapore

Sponsors (4)

Lead Sponsor Collaborator
Singapore General Hospital Baylor College of Medicine, Duke-NUS Graduate Medical School, National University Health System, Singapore

Country where clinical trial is conducted

Singapore, 

Outcome

Type Measure Description Time frame Safety issue
Primary Glycine kinetic Differences in glycine kinetic measurements between obese subjects and controls, and within obese subjects after bariatric surgery Baseline for all subjects and 5-12 months after bariatric surgery for morbid obesity group
Primary Insulin sensitivity Differences in insulin sensitivity between obese subjects and controls, and within obese subjects after bariatric surgery Baseline for all subjects and 5-12 months after bariatric surgery for morbid obesity group
See also
  Status Clinical Trial Phase
Completed NCT03142633 - MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Recruiting NCT05354245 - Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL) N/A
Completed NCT03383822 - Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Suspended NCT03652987 - Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
Completed NCT04203238 - Potato Research for Enhancing Metabolic Outcomes N/A
Recruiting NCT03658564 - Preoperative Oral Carbohydrate Treatment Minimizes Insulin Resistance N/A
Completed NCT04183257 - Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics Phase 4
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT03627104 - Effect of Dietary Protein and Energy Restriction in the Improvement of Insulin Resistance in Subjects With Obesity N/A
Completed NCT05124847 - TREating Pediatric Obesity N/A
Active, not recruiting NCT03288025 - Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE) N/A
Completed NCT03809182 - Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels. Phase 4
Completed NCT01809288 - Identifying Risk for Diabetes and Heart Disease in Women
Completed NCT04642482 - Synbiotic Therapy on Intestinal Microbiota and Insulin Resistance in Obesity Phase 4
Terminated NCT03278236 - Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men? N/A
Not yet recruiting NCT06159543 - The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes N/A
Not yet recruiting NCT05540249 - Pre-operative Carbohydrates in Diabetic Patients Undergoing CABG N/A
Withdrawn NCT04741204 - Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer Phase 4